---
title: Product Pipeline
---

[![Logo](https://www.healthbioai.com/hubfs/HealthBio%20logo%20files%201%20of%202/Logo%20with%20white%20tagline.png) ](https://www.healthbioai.com/?hsLang=en)

[ ORDER TEST ](https://longcovid.cellyhealth.com/index.php)

![Group 4](https://www.healthbioai.com/hubfs/Group%204.png)

#### ACCELERATING

# Clinical *Rx* Development *and Diagnostic Research* toward Commercialization

![Group 47617](https://143975299.fs1.hubspotusercontent-eu1.net/hubfs/143975299/Group%2047617.png)

#### DIAGNOSTICS PORTFOLIO (INCELLKINE ASSAY)

![ICON - DIAGNOSTICS (1)](https://143975299.fs1.hubspotusercontent-eu1.net/hubfs/143975299/ICON%20-%20DIAGNOSTICS%20(1).png)

![HEALTHBIO DIAGNOSTICS CHART-1](https://www.healthbioai.com/hubfs/HEALTHBIO%20DIAGNOSTICS%20CHART-1.png)

- **Lab partners located in USA and Globally to process patient testing**

![Group 47617](https://143975299.fs1.hubspotusercontent-eu1.net/hubfs/143975299/Group%2047617.png)

#### RX THERAPEUTIC INNOVATION

In January, 2024, our application was** accepted by the FDA to proceed with a Randomized Clinical Trial for the Treatment of Long COVID/Post Acute Sequelae of COVID (PASC)** with Selzentry® (maraviroc) in Combination with Lipitor (atorvastatin). The clinical trial will support a New Drug Application (NDA) filing through the 505(B)(2) pathway of the Federal Food, Drug, and Cosmetic Act (FDCA).

 

The initial focus is on the diagnosis and treatment of Long Covid with ongoing evaluation of other indications that present significant unmet medical needs.

![ICON - RX](https://www.healthbioai.com/hubfs/ICON%20-%20RX.svg)

![HEALTHBIO RX THERAPEUTIC INNOVATION CHART](https://www.healthbioai.com/hubfs/HEALTHBIO%20RX%20THERAPEUTIC%20INNOVATION%20CHART.png)

![Group 47617](https://143975299.fs1.hubspotusercontent-eu1.net/hubfs/143975299/Group%2047617.png)

#### BIOMETRIC REMOTE MONITORING

![ICON - BIOMETRIC DEVICE](https://www.healthbioai.com/hubfs/ICON%20-%20BIOMETRIC%20DEVICE.svg)

![HEALTHBIO BIOMETRIC MONITORING CHART](https://www.healthbioai.com/hubfs/HEALTHBIO%20BIOMETRIC%20MONITORING%20CHART.png)

![WATCH](https://143975299.fs1.hubspotusercontent-eu1.net/hubfs/143975299/WATCH.png)

## An integral personal device for your immune health and wellness

Biometric wearable helps patients track symptoms

[Learn More](https://www.healthbioai.com/product-pipeline#remote)

#### REMOTE MONITORING DEVICE

## Giving Patients Confidence in Monitoring Their Health

#### Long-lasting battery

7-10 day long-lasting battery life

#### water & shock resistant

5 ATM Water and Shock Resistant

#### VITAL HEALTH TRACKING

Tracks multiple vital health functions and activities important to managing your immunologic symptoms

#### 30 DAY DATA PERIOD

A month of health data memory

#### continuous tracking

Allows uninterrupted tracking for longer intervals for more accurate tracking

#### FCC & IC COMPLIANT

This equipment has been tested and found to comply with the limits for a Class B digital device, pursuant to Part 15 of the FCC Rules

## Data that everyone can understand

![](https://www.healthbioai.com/hubfs/Group%2047533.svg)

Allows input of your symptoms and severity, laboratory test results, medications, supplements, and other daily information on your health status

![Group 47533](https://www.healthbioai.com/hubfs/Group%2047533.svg)

Data can we shared with others to compare and discuss

![](https://www.healthbioai.com/hubfs/Group%2047533.svg)

iPhone and Android compatible

![](https://www.healthbioai.com/hubfs/Group%2047533.svg)

Compatible with  Apple and Android watches

![Group 47533](https://www.healthbioai.com/hubfs/Group%2047533.svg)

Reminder alerts for when to take your prescription medications, supplements, vitals and other important activities.